Eli Lilly stock drops 2% as Zepbound arthritis data and Ventyx deal sink in
New York, Jan 9, 2026, 17:30 EST — After-hours Eli Lilly and Co shares fell nearly 2% on Friday, closing at $1,063.56, after swinging between about $1,063 and $1,104 in the session. The stock was little changed after hours. The pullback comes as the drugmaker’s stock cools off from a fresh 52-week high set on Thursday, with traders quick to lock in gains after a fast run. The broader market rose on the day, but Lilly logged a second straight decline and ended the session about 6% below that recent peak. (MarketWatch) The latest company catalyst landed late Thursday, when